These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 14959700)

  • 1. Lipid abnormalities during ART: it's the drug, not the class.
    Moyle GJ
    AIDS Read; 2004 Jan; 14(1):15-6, 20-2. PubMed ID: 14959700
    [No Abstract]   [Full Text] [Related]  

  • 2. Hierarchical modeling gave plausible estimates of associations between metabolic syndrome and components of antiretroviral therapy.
    Young J; Glass TR; Bernasconi E; Rickenbach M; Furrer H; Hirschel B; Tarr PE; Vernazza P; Battegay M; Bucher HC;
    J Clin Epidemiol; 2009 Jun; 62(6):632-41. PubMed ID: 19108985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of antiretroviral choice on hypercholesterolaemia events: the role of the nucleoside reverse transcriptase inhibitor backbone.
    Jones R; Sawleshwarkar S; Michailidis C; Jackson A; Mandalia S; Stebbing J; Bower M; Nelson M; Gazzard BG; Moyle GJ
    HIV Med; 2005 Nov; 6(6):396-402. PubMed ID: 16268821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiretroviral drugs with adverse effects on adipocyte lipid metabolism and survival alter the expression and secretion of proinflammatory cytokines and adiponectin in vitro.
    Lagathu C; Bastard JP; Auclair M; Maachi M; Kornprobst M; Capeau J; Caron M
    Antivir Ther; 2004 Dec; 9(6):911-20. PubMed ID: 15651750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Editorial comment: boosted PIs and metabolism--it's not just the ritonavir.
    Moyle GJ
    AIDS Read; 2005 Oct; 15(10):531. PubMed ID: 16265769
    [No Abstract]   [Full Text] [Related]  

  • 6. Antiretroviral therapy with or without protease inhibitors impairs postprandial TAG hydrolysis in HIV-infected men.
    Ware LJ; Jackson AG; Wootton SA; Burdge GC; Morlese JF; Moyle GJ; Jackson AA; Gazzard BG
    Br J Nutr; 2009 Oct; 102(7):1038-46. PubMed ID: 19480729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute pancreatitis associated with different combination therapies in patients infected with human immunodeficiency virus.
    Guo JJ; Jang R; Louder A; Cluxton RJ
    Pharmacotherapy; 2005 Aug; 25(8):1044-54. PubMed ID: 16207094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Editorial comment: tenofovir-related nephrotoxicity--who's at risk?
    Gupta Samir K
    AIDS Read; 2007 Feb; 17(2):102-3. PubMed ID: 17323509
    [No Abstract]   [Full Text] [Related]  

  • 9. A review of the aetiology of dyslipidaemia and hyperlipidaemia in patients with HIV.
    Moyle G
    Int J STD AIDS; 2005 Oct; 16 Suppl 1():14-20; discussion 20-2, 41-3. PubMed ID: 16238827
    [No Abstract]   [Full Text] [Related]  

  • 10. Boosted protease inhibitor-based or nonnucleoside reverse transcriptase-based HAART: is there a best choice for antiretroviral-naive HIV-1 infected patients?
    Cuzin L; Allavena C; Morlat P; Dellamonica P
    AIDS Rev; 2008; 10(4):205-11. PubMed ID: 19092976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benefit of switching from a protease inhibitor (PI) to nevirapine in PI-experienced patients suffering acquired HIV-related lipodystrophy syndrome (AHL): interim analysis at 3 months of follow-up.
    Negredo E; Paredes R; Bonjoch A; Tuldrà A; Fumaz CR; Gel S; Garcés B; Johnston S; Arnó A; Balagué M; Jou A; Tural C; Sirera G; Romeu J; Cruz L; Francia E; Domingo P; Arrizabalaga J; Ruiz I; Arribas JR; Ruiz L; Clotet B
    Antivir Ther; 1999; 4 Suppl 3():23-8. PubMed ID: 16021868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Enduringly effective and tolerable initial therapy of HIV. Even after 5 years no resistance].
    MMW Fortschr Med; 2003 Dec; 145(50):60-1. PubMed ID: 14963980
    [No Abstract]   [Full Text] [Related]  

  • 13. The metabolic syndrome: news from the 4th International AIDS Society Conference.
    Valenti WM
    AIDS Read; 2007 Sep; 17(9):435-7. PubMed ID: 17902223
    [No Abstract]   [Full Text] [Related]  

  • 14. HIV antiretroviral treatment alters adipokine expression and insulin sensitivity of adipose tissue in vitro and in vivo.
    Lagathu C; Kim M; Maachi M; Vigouroux C; Cervera P; Capeau J; Caron M; Bastard JP
    Biochimie; 2005 Jan; 87(1):65-71. PubMed ID: 15733739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mild-to-moderate symptoms during the first year of antiretroviral therapy worsen quality of life in HIV-infected individuals.
    Mannheimer SB; Wold N; Gardner EM; Telzak EE; Huppler Hullsiek K; Chesney M; Wu AW; MacArthur RD; Matts J; Friedland G;
    Clin Infect Dis; 2008 Mar; 46(6):941-5. PubMed ID: 18279044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ritonavir-boosted protease inhibitors, Part 2: cardiac implications of lipid alterations.
    Cohen CJ
    AIDS Read; 2005 Oct; 15(10):528-32, 537-8. PubMed ID: 16265768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nucleoside reverse-transcriptase inhibitor use, cirrhosis, and end-stage liver disease in HIV-infected patients.
    Remtulla RA; Decker CF
    Clin Infect Dis; 2008 Nov; 47(9):1233-4; author reply 1234. PubMed ID: 18831698
    [No Abstract]   [Full Text] [Related]  

  • 18. Adipocytes targets and actors in the pathogenesis of HIV-associated lipodystrophy and metabolic alterations.
    Gougeon ML; Pénicaud L; Fromenty B; Leclercq P; Viard JP; Capeau J
    Antivir Ther; 2004 Apr; 9(2):161-77. PubMed ID: 15134178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the risks of atherosclerotic events versus death from other causes associated with antiretroviral use.
    Kwong GP; Ghani AC; Rode RA; Bartley LM; Cowling BJ; da Silva B; Donnelly CA; van Sighem AI; Cameron DW; Danner SA; de Wolf F; Anderson RM
    AIDS; 2006 Oct; 20(15):1941-50. PubMed ID: 16988515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current HIV therapeutics: mechanistic and chemical determinants of toxicity.
    Chiao SK; Romero DL; Johnson DE
    Curr Opin Drug Discov Devel; 2009 Jan; 12(1):53-60. PubMed ID: 19152213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.